Thank You for Another Wonderful Year!

Because of you we have raised over $1 million to fund the crucial cause of RVCL Research

We thank you!

2021 Sponsors

Bob and Susan Wislow Foundation
Cooper Steel
Inclenberg Investments
Jacksonville Jaguars
Ralph Senst & Karen Zelden
Rock Solid
Russ & Allison Burns
Busey Bank
Chris & Carolyn McKee
Flooring Systems
Michele & Don Luz

Thompson Coburn
Tom & Michelle Sieckhaus
Williamette Management Associates
Alex Solak
Bob & Nancy Russell
Brad Nardick
Chicago Commercial Construction
Concrete Strategies
Connelly Electric
Curran Contracting
Dan & Emily North
David & Debbie Hutnik
Enterprise Bank
Facade Concepts Inc.

Fifth-Third Bank
Flom Foundation
Greenberg Traurig, LLP
Herman Schnieder
Husch Blackwell
Jay and Karen Case
Jewish Community Foundation
Lamar & Lisa Johnson
Liberty Mutual
Mackey Mitchell
Mark Agnew
Matt & Dee Moran
Michelle Levy & Jim Panella

Pat Moriarity
Payne Crest Electric
Rubin Brown
Shambaugh & Sons
Sherwin Williams
Stifel Bank
The John Buck Company
The Michael Clark Family
Tim Crowley
Tony & Bobbie Schofield
Villa Lighting
Wies Drywall
Zach Graham

Our united fundraising has strengthened RVCL research internationally, and accomplished:

  • Completing the first clinical trial and a long-term patient monitoring study
  • Starting second and third clinical trials in 2020
  • Generating 3 models of the disease, which will permit testing of new therapies
  • Identifying candidate drugs that we hope will lead to personalized therapies
  • Initiating first studies of gene editing, which may lead to a new treatment approach
  • Recruiting a collaborative team of top researchers from Washington University in Saint Louis, the University of Chicago, the University of Michigan, and from private biotech. The group combines medical, scientific, and drug-development expertise in their search for a cure. The Clayco Foundation indirect rate is zero with Washington University School of Medicine.
  • For more information on our accomplishments and research, go to

Illumination is an exceptional evening of celebration, community, and fundraising set in a landscape of illuminated interactive installations, delightful playgrounds of light, illuminated participatory contraptions, lit characters, fiery parades, glowing processions and radiant spectacle.


Leading the cure for Retinal Vasculopathy with Cerebral Leukodystrophy (RVCL)

The Clayco Foundation is determined to find a cure for Retinal Vasculopathy with Cerebral Leukodystrophy (RVCL). RVCL is a rare and fatal genetic condition affecting the central nervous system, causing the deterioration of small blood vessels in the brain and eyes of those affected. Most patients begin experiencing vision loss and strokes in their early 40s, and have an average lifespan of eight years following their first symptoms. Rare disease affects nearly all of us. 30 million people in the United States are living with some form of rare disease; that’s close to 1 in 10 people. We believe that, together, we can make a difference building on last year’s success. We look forward to your partnership and exceeding our goals in 2020.

In addition to raising funds for an invaluable cause, Illumination is devoted to discovering, attracting, mentoring, and directing over 100 diverse professional creators, emerging artists, and performing partners who are all committed to amplifying the Art of Light — illuminated sculpture, installation, experience, costume, objects, and effects. Illumination’s collaboration with the artist community makes for a particularly special event symbolic of hope and transformation.

Come help us cast a light on rare disease!

Our Inspiration

Ellen was diagnosed in 2005 with a terminal genetic disease that effects blood vessel reproduction (or lack of) throughout the body. While the disease impacted everything, the main damage was to the eyes and brain. Ellen’s outlook was very grim and expected to move at a rapid pace.

Because she was in great physical shape and the toughest person we have ever known, she blew past all the doctors’ dire predictions and even with major evidence of damage, continued past their projections and held on to an amazing quality of life up until the last several weeks.

Never in all her trials and adverse conditions did she ever complain or whine or do anything that was less than courageous and downright classy. In her last moments, she was beautiful. She was in no pain and was not suffering.

Ellen and Bob started dating when they were 15. Married for 25 years. 5 children and 3 grandchildren, they had an extraordinary run. Their relationship was full of ups and downs. Strengths and weaknesses, heartache, tragedy and blessings beyond their young, wild dreams. Ellen was a passionate person, defined purely by her fierce motherhood and giving spirit. She cared about everyone she met and made no foes along her journey.

Our Plan

The Clayco Foundation is a tax exempt 501(c)(3) entity that supports multiple charitable organizations in the communities where Clayco, Inc. is actively engaged in business.

Although The Clayco Foundation supports numerous charitable organizations, all of the donations raised through Illumination directly fund research for Retinal Vasculopathy with Cerebral Leukodystrophy (RVCL); a very rare, genetic condition that affects the central nervous system.

The John Atkinson Research Lab at Washington University is:

  • Creating the best mouse model system to determine how TREX mutations disrupt normal cellular function, understand how it works (pathophysiology) in a living system, and screen for the most effective therapeutic agents.

  • Collaborating with pharmaceutical companies and the FDA to gain access to or produce a drug called aclarubicin (ACM) for human use.

  • Leading collaboration of four key research groups: Washington University in St. Louis, University of California, National Institutes of Health, and University of Texas Southwestern.

  • Planning a scientific symposium to provide enhanced data sharing, discussion of results and expansion of our knowledge base with researchers in the U.S. and globally.

This all leads to potential positive implications for:

  • Systemic Lupus Erythematosus

  • Diabetic Retinopathy

  • Aging disorders

  • Blood vessel deterioration disorders (vasculopathies)

  • As well as other related diseases

Sponsorship Opportunitues

In the past 5 years, we have proudly raised $4.5 million directed towards cutting edge, leading research to cure RCVL. For information on how you can invest in our research, join our team, and save lives, please contact Roz Skozen, Director of Community Relations, Clayco, at [email protected] or  312.239.1569

Lifetime Contributions to the Clayco Foundation

The Clayco Foundation would like to thank its contributors who’s loyalty and friendship have been key to achieving our goals. Thank you to the donors and friends who have consistently made significant contributions since our inception. Collectively, these funders have generously contributed a total of over $5 Million and individually given up to $100,000 each. We are exceedingly grateful.

Platinum Circle

Bob & Susan Wislow
Karen Zelden & Ralph Senst
Lawrence & Christy Chapman
Russ & Allison Burns

Gold Circle

Ann Anderson
Chris & Carolyn McKee
David Gochman
David Pavlik
Gregg Scurto & Hermann Schneider
Harold Gross
Ivana & James Preuss
Jay & Karen Case
John Dillon
Lamar & Lisa Johnson with LJC
Michele & Donn Lux
Scott Goodman
The Nardick Family
Tom & Michelle Sieckhaus
Zach Graham

Silver Circle

Alan Schachtman & Susanne Hutcheson
Alex Ross
Alex Solak
Alpine Acoustics
Amjad Alkadri PC
Andy Ray with ABCO
Anthony Sansone
Bartkowski Group
Bill Brown with Ben Hur Construction
Bill Kuempel
Bob Blitz with Blitz Baedgett Deutsch
Bob Carlson
Bob Trainor
Bob & Nancy Russell
Brad Nardick
Bryan Hinton
Buzz Ruttenberg
Carmen Hernandez
Caroline Saunders
Chad Showalter
Chicago Commercial Construction
Chuck Hayes with Hayes Industries
CK II Contracting
Clifton Larson Allen
Clover Architectural Products
Commerce Bank
Concrete Strategies
Connelly Electric
Construction Specialties
CTI Ready Mix
Curran Contracting
Dan & Emily North
Daniel Gibbons
David & Debbie Hutkin
Dormakaba USA
Dyer Family
Eco Recycling Inc.
EJ Equipment
Enterprise Bank
ES Windows
Evan Shook with FacadeTek
F.E. Moran
Facade Concepts Inc.
Fifth-Third Bank
Flodd Bros. Disposal CO
Flom Foundation
Gina Suarez with Harmon Inc
Global Distribution
Greenberg Traurig, LLP
Herman Schnieder
Husch Blackwell
Jack Mullen
Jabod & Hefner
Jay & Karen Case
Jerry Hogan with Façade Concepts
Jewish Community Foundation
Jim Eshleman
Jodi Cloninger
Joe Olson
John & Betsey McLinden Foundation
John & Sharon Hoffman
John Atkinson
John Colwell
John Thomas

Jones, Skelton & Hochuli
Joseph Alonzo with Sunbelt Rentals
JR Kibbon
Kapil Khanna
KCP Concrete Pumps Ltd.
Kevin & Patty McKenna
KJ & LS Rosenthal
Kurt Jaeger
Lamar & Lisa Johnson
Liberty Mutual
Mackey Mitchell
Mark Agnew
Mark Marvin with Marvin Group
Mark Novack
Martin Trainor
Mary Ann Lemonds
Matt and Dee Moran
Michael Alvarez
Michael Johnson
Michael Johnson with Kone
Michael Latiner
Michael Peterson with USAFP
Michael Zhou
Michelle Levy & Jim Panella
Mike & Deborah Wurtsbaugh
Missy Lavender
Morgan Stanley
Nancy & Bob Russell
Nancy Schnurbusch
Obrien Investment
Pam & Bud Pharris
PAt Moriarity
Paul Freier
Paul Grosse with Carollton Bank
Penn Services
Performance Architectural
POB Capital
Rosch Company
Roy Eller with Patriot Ready Mix
Roz Skozen
Ryan Bain
Rubin Brown
Sam McBride
Scott Wiercinski
Shambaugh & Sons
Sherwin Williams
Stifel Bank
The Conservation Center
The John Buck Company
The Levy Family
The Michael Clark Family
The Net Lease Group
Tim Crowley with PimCo
Tom & Lisa Carnahan
Tony & Bobbie Schofield
Tory Cosich with Proven IT Systems
Turner Construction
US Private Wealth Management
Villa Lighting
Vinod Jaskula-Ranga
White & Williams
Wies Drywall
Zach Graham
Zeke Miller

Gratitude to Our Past Food and Beverage Sponsors – Thank You!

In Kind Sponsors

Prime Scaffold
AV Chicago
Zhou Brothers
Burris Equipment
Carmen Maugeri
Mariane Ibrahim Gallery
Neal Verplank
Castle Party Rentals